Carlyle Group Inc
NASDAQ:CG
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
37.23
54.81
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q3-2024 Analysis
Carlyle Group Inc
Carlyle Group has undergone significant strategic changes over the past 1.5 years to enhance performance. Key initiatives included realigning the compensation model, enhancing leadership, and prioritizing margin expansion. These proactive measures, combined with a revival of activity across the firm, led to one of the best quarterly performances in its history.
In Q3 2024, Carlyle achieved record fee-related earnings (FRE) totaling $278 million, marking a 36% increase year-over-year. Notably, the FRE margin reached 47%, a substantial rise of over 10 percentage points compared to last year. Carlyle is on track to meet its 2024 FRE target of $1.1 billion, representing nearly 30% growth from the previous year.
Carlyle's investment portfolio saw robust performance, with a nearly 30% increase in net accrued performance revenues compared to the previous quarter, amounting to $2.8 billion. This performance indicates a potential of nearly $8 per share in future earnings for shareholders. The firm expects continued growth in capital markets fees, having already generated record annual transaction fees despite a relatively sluggish M&A and IPO environment.
Carlyle raised $9 billion in new capital during the quarter and has accumulated $43 billion over the past year. The firm anticipates a strong fourth quarter, targeting about $40 billion in inflows for the full year. The fundraising momentum is driven primarily by key sectors within its investment strategy, including private equity and solutions.
The recent U.S. election has alleviated market uncertainty, fostering a more favorable environment for IPOs and M&A activities. This creates an optimistic backdrop for Carlyle's capital markets strategies. The Federal Reserve's stance on interest rates further supports economic growth, expected to favor Carlyle's investment activities. There's been a notable uptick in IPO activity in recent months, with a 30% increase in listings.
Carlyle's initiatives in capital markets and wealth management have shown encouraging results. With considerable growth in global wealth AUM, which surged by 70% year-over-year, the firm is well-positioned to capitalize on this momentum going forward. Furthermore, the focus on asset-backed finance and regulatory changes in credit also signify areas ripe for expansion in 2025.
Carlyle remains committed to returning capital to shareholders, having repurchased approximately $150 million in shares during the quarter, bringing the total repurchases to nearly $480 million for the year. With over $900 million remaining in its buyback authorization, the firm aims to balance shareholder returns with investments for future growth while maintaining strong operational leverage.
Looking toward 2025 and beyond, Carlyle expresses confidence in maintaining low double-digit growth in FRE and has identified robust pathways for sustainable fundraising and revenue generation. Despite headwinds in certain segments, strategic operational improvements and strong market positions across various asset classes are expected to accelerate long-term value creation for shareholders.
Thank you for standing by, and welcome to The Carlyle Group's Third Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.
And now I'd like to introduce your host for today's program, Daniel Harris, Head of Investor Relations. Please go ahead, sir.
Thank you, Jonathan. Good morning, and welcome to Carlyle's third quarter 2024 earnings call. With me on the call this morning is our Chief Executive Officer, Harvey Schwartz; and our Chief Financial Officer and Head of Corporate Strategy, John Redett.
Earlier this morning, we issued a press release and a detailed earnings presentation, which is available on our Investor Relations website. This call is being webcast and a replay will be available.
We will refer to certain non-GAAP financial measures during today's call. These measures should not be considered in isolation from or as a substitute for measures prepared in accordance with generally accepted accounting principles. We have provided a reconciliation of these measures to GAAP in our earnings release to the extent reasonably available. Any forward-looking statements made today do not guarantee future performance, and undue reliance should not be placed on them.
These statements are based on current management expectations and involve inherent risks and uncertainties, including those identified in the Risk Factors section of our annual report on Form 10-K that could cause actual results to differ materially from those indicated. Carlyle assumes no obligation to update any forward-looking statements at any time.
In order to ensure participation by all that's on the line today, please limit yourself to 1 question and return to the queue for any additional follow-ups.
With that, let me turn the call over to our Chief Executive Officer, Harvey Schwartz.
Thanks, Dan. Good morning, everyone, and thank you for joining us.
Over the past 1.5 years, we undertook several strategic actions to drive better performance, including realigning our compensation model, appointing new leadership, and prioritizing margin expansion, among other initiatives. As we stand here today, you're beginning to see the early impacts of those steps. These actions, combined with a pickup in activity across the platform generated, one of the best quarterly performances in the firm's history.
We delivered record quarterly fee-related earnings, up 36% versus the third quarter of 2023, and our best-ever FRE margins at 47%, up more than 10 percentage points since last year. Overall, we are on track to hit our FRE target of $1.1 billion for the year.
Our underlying investment portfolio is performing very well. This drove strong corporate private equity fund appreciation that fueled the nearly 30% increase in our net accrued performance revenues compared to the prior quarter. This accrual represents nearly $8 per share of future earnings for our shareholders.
As we talked about previously, capital markets was a significantly under-leveraged part of our platform that is gaining substantial momentum. This is the direct result of proactive steps we've taken to increase alignment around transaction fee generation.
Including closed Q4 activity, we've already generated our highest level of annual transaction fees. This despite a still subdued M&A and IPO environment Obviously, we expect further growth in capital markets fees.
On fundraising, we raised $9 billion of new capital in the quarter and have raised $43 billion over the past 12 months. We anticipate a very strong fourth quarter of capital raising to close out the year, and we continue to target about $40 billion of inflows for the year.
Now switching to the macro environment. Obviously, let's start with the election results. Being past the election has removed market uncertainty, first and foremost. Markets like certainty, and you're seeing that broadly across capital markets, particularly in the stock market yesterday.
Over the medium to long term, this should be a further catalyst for IPOs, M&A and key sectors we invest in. This should be an environment in which we are well positioned to capitalize on monetization opportunities and put capital to work.
Prior to election, we had already seen the U.S. Federal Reserve shift in stance on interest rates, and that was a clear sign that we entered a new era monetary policy, and that inflation has stabilized. The election certainty and the change in monetary policy are a powerful combination, supporting economic growth and our business.
We're already seeing a significant uptick in IPO activity this year. There's been a 30% increase in listings and a 50% increase in IPO proceeds in the first 9 months of this year. We've seen this trend benefit our portfolio as well, with 2 significant IPOs in just the last month. StandardAero in the U.S. and Rigaku in Japan. StandardAero marked the second largest sponsored-backed U.S. IPO of the year and the best first day performance for U.S. IPO, raising over $1 billion, this since 2021.
Aerospace, defense and government services is a key power ally for Carlyle. Our roots in D.C. and more than 30-year history in this space is a core differentiator for us. This was the largest aerospace IPO ever and demonstrates that the market is starved for high-quality businesses and growth outside of the tech sector.
Rigaku was the second biggest Japanese IPO this year and the largest ever sponsored-backed IPO in Japan. Japan remains a very attractive market for us.
This year's improved market sentiment has driven stronger investment activity and a more active pipeline across our platform, reflecting our ability to act on opportunities in a dynamic environment. A more liquid realization backdrop and strong underlying portfolio performance have supported higher investment returns.
Our 2 largest U.S. buyout funds were up north of 7% each this quarter and our 2 largest Asia buyout funds were up 9% and 13%, respectively. This quarter represented the third largest quarterly increase in net accrued performance revenues in our firm's history. Over $600 million of net performance revenues were generated.
Switching to global wealth, another area of strategic focus, we're seeing strong momentum across the platform where we benefited from a record $1.8 billion of wealth inflows. Our wealth inflows this quarter were nearly 3x the amount in the previous quarter, and our global wealth AUM is up 70% year-over-year.
Part of the momentum is our newly launched secondaries wealth solution, Cap M, which is seeing very strong early traction with advisers and their clients. We're also making progress in our private equity wealth product and are still on track to launch in 2025.
Another area where we see accelerating growth is in asset-backed finance. We continue to identify differentiated partnerships with specialty finance companies to further bolster our origination capabilities and give us a data edge in the market.
We've also seen record leveraged loan and CLO issuance in 2024. Loan spreads have tightened to post-GFC levels and demand for new paper is outpacing supply. Full year 2024 U.S. leveraged loan issuance is expected to exceed $1 trillion for only the third time.
At Carlyle, the team has been very busy with our leading CLO business having priced 22 transactions globally, on track to be a record year of resets and transactions priced.
The opportunities in our insurance business remain quite significant. Fortitude has grown its general account assets by almost 70% in the past year. It has increased its excess capital position to more than $1 billion, allowing us to pursue a robust reinsurance pipeline. We also continue to grow our relationships with insurance clients broadly and further leverage our private investment-grade and asset-backed finance capabilities in this important channel.
To wrap things up, we had a strong third quartile with Carlyle extremely well positioned to capitalize on an improving macroeconomic environment. Our leadership team remains laser-focused on driving performance and accelerating growth to drive long-term value for you, our shareholders.
With that, let me now turn the call over to John.
Thanks, Harvey. Good morning, everyone. We are very pleased with the progress we've made over the last year. The business is just performing much better than it was 12 months ago, and we are also benefiting from a material step-up in market activity.
The actions we've taken over the past year include improving FRE margins, activating the capital markets flywheel, improving investment performance, realigning our compensation strategy, appointing new leadership, and we continue to see benefits of the revised capital allocation strategy we implemented this year.
These actions have generated significant operating leverage and momentum across our business, including record AUM of $447 billion, up 17% compared to last year. Record fee earning AUM of $314 billion, which has grown at a 15% CAGR over the last 5 years. Record quarterly FRE of $278 million at a 47% FRE margin. And strong performance in our corporate private equity funds, which drove a material shift higher in net accrued performance revenues to $2.8 billion.
We produced $367 million in DE for the quarter or $0.95 in DE per share. And year-to-date DE per share of $2.74 is 15% higher than last year.
Now let's cover 3 important areas: fee-related earnings, appreciation in our corporate private equity business, and capital return to shareholders. Starting with fee-related earnings. FRE increased to $278 million in the quarter, up more than 35% from the third quarter of 2023. We are on track to hit our 2024 FRE target of $1.1 billion, which would represent nearly 30% year-over-year growth. Pending fee-earning AUM stands at $21 billion, our highest level since the third quarter of 2021.
In the fourth quarter, we expect to activate fees on our latest Japan buyout fund. And in 2025, we'll activate fees on our new U.S. opportunistic real estate fund.
Year-to-date capital market fees were more than 80% higher than a year ago. We will see a significant increase in Q4 capital market fees as several large transactions have already closed. We expect to see further growth over time as our focus on expanding our capabilities in this area should support a higher level of capital markets activity.
Let's turn to fund appreciation. As Harvey noted, our corporate private equity fund appreciation was up significantly. Driving this performance in the U.S. was strong EBITDA growth, up 15% year-over-year, and continued margin expansion across the portfolio. This positive underlying growth is driving significant value creation at the fund level, and our portfolio is well positioned to further benefit from a better exit environment.
Net accrued performance revenues increased more than $600 million to $2.8 billion. As we noted, this represents almost $8 of pretax earnings per share for our shareholders.
Finally, let me touch on capital allocation. We continue to balance deployment of capital into our business and returning capital to our shareholders. We repurchased $150 million of shares in the third quarter, bringing total repurchases to almost $480 million year-to-date.
Total shares outstanding are down for the second consecutive year, and we have over $900 million remaining on our share repurchase authorization. It is our intent to continue repurchasing shares. However, our first priority is investing for growth.
Wrapping up, we continue to focus on delivering strong results for our shareholders. We are on track to achieve the financial targets that we laid out for 2024. And we have increasing conviction in the ability of our investment platform to drive higher earnings for shareholders over time.
With that, let me turn the call over to the operator for your questions.
[Operator Instructions] Our first question comes from the line of Alex Blostein from Goldman Sachs.
So maybe just to kick us off with a little bit of a macro question, obviously, related to the election, and I know you made a couple of comments in your opening remarks. But curious how you think the Trump administration could impact activity in the alt space, both on a macro set of activity side, but also any regulatory items you're paying particular attention to and how that could impact Carlyle.
Thanks, Alex. Well, maybe take a step back for a minute because, obviously, the market had an unexpectedly strong reaction to the outcome. I think that has a lot to do with expectations, obviously, going in. David was on TV yesterday, David Rubenstein, and he made a comment. He said something to the effect of the losers in this process were the pollsters. And he said, maybe we need to get AI involved in the polling process.
And now taking that quite seriously, coming into this election, there were concerning headlines about the fact that we might not have a result for days, if not weeks, possibly months. That creates a lot of uncertainty in CEO's minds and how they think about strategy, how they think about committing capital, making decisions. And I think the election certainty and having the outcome behind was obviously a very significant relief factor for the market.
Now from a policy perspective, whether it's sustained or further cuts in the tax regime, whether it's a lighter regulatory touch, all these things will get translated in CEOs' minds, Boards, our portfolio of companies in really confidence around the operating environment, and that will lead to more decision-making. It should lead to more M&A activity.
If you're not quite certain whether or not you can get your transaction done from a strategic perspective, obviously, that gives you a lot of pause as a Board. And so I think this is what the market is reacting to.
Now in terms of our business, we're already seeing lots of tailwinds in the business. You see it in the numbers today. A big part of that is the strategic actions the management team has taken. A big part of that is the market environment. And when we saw the stability of the interest rates flattening out, I just think election certainty, future policies, plus Fed policy normalizing, I think Fed policy normalizing and being past the election, that's a pretty powerful 1-2 punch for markets and for our business specifically at Carlyle.
And Alex, the only thing I would add is, it's a little bit echoing what Harvey said, I spoke to a couple of our portfolio company CEOs yesterday, and I would just echo the common theme was they feel like the election certainty, the removal of the election uncertainty will elevate confidence levels. And that obviously is -- that's good for capital markets and that's good for M&A. And all those things being better, stronger, we think it's good for our business.
And our next question comes from the line of Ken Worthington from JPMorgan.
I wanted to dig into performance. You called out and are having some nice exits, StandardAero, Rigaku, and it seems like there's more to come. At the same time, the net IRR in CP VII sort of remained at 8% despite the jump in accrued carry. And if you look at CEP V, the IRR fell to 4%. How should we think about the performance metrics developing in buyout if and as you get the exits you expect in this improving environment, and I think we, the investment community, see performance in buyout as a headwind? Do you see that changing or have a different view, again, given the environment? And if so, is it big enough to change the fundraising trajectory?
Ken, it's John. So look, we saw a very strong improvement in performance within our corporate private equity business, and as Harvey alluded to this, it was particularly in the U.S. and Asia, the net performance fee accrual was up nearly $600 million, $700 million in total corporate private equity drove the vast majority of that. It's one of the best quarters we've ever had.
Look, the appreciation we're seeing in our U.S. and Asia funds is very healthy. What I like about it is a big driver of that's just operational improvements. We're seeing good EBITDA growth, good revenue growth, good margin expansion. And I think it reflects we're in a strong economy, and better exit markets only add to that improved performance.
And look, we've been very, very open on this topic in previous calls, we've been very focused as a leadership team on improving our performance in the private equity business. And I think when you look at the results this quarter, it's -- the numbers are starting to reflect the focus we have on this business.
We like the trajectory of this business, and we know this is a business that over time we can grow. I think the performance improvement in the U.S. is particularly notable in CP VII, you're not going to see the net IRR materially change as we're just getting through the catch-up phase, but you did see a 100 basis point pickup in 1 quarter on the gross IRR. I would say on CP VIII, our most recent vintage, I would focus on the gross IRR as that fund is not fully deployed, so the net IRR is a lot less relevant.
And our next question comes from the line of Ben Budish from Barclays.
I wanted to ask about your outlook for 2025 a little bit in terms of what you expect on the credit side. I think on the private equity side, you're kind of done with a lot of the major fundraises and it sounds like you're expecting a big pickup in activity. Same with the solutions, as I recall, you should be mostly done kind of fundraising there by the end of this year. So on the credit side, what's sort of your expectation for fundraising activity? What else are you kind of thinking about in terms of how to build, grow, develop that platform?
Across credit and insurance, the momentum is quite significant. And when I say that, I'm really talking you about, across the strategic part, opportunities in credit, but all the way through the capital stack, as I mentioned in my previous remarks, around asset-based finance. So the private investment-grade market just continues to grow, and we're very well positioned with that, in part because of our partnership with Fortitude and all the insurance intelligence we have from that, plus their excess capital position.
So I feel very optimistic about the credit markets. And we talked about the CLO activity, spreads at this rate, spreads at these levels, it's quite attractive. And so we expect activity to remain quite high.
And our next question comes from the line of Patrick Davitt from Autonomous Research.
I think there's a lot of the positives from the Trump win for the ultra fairly obvious, and you went through a lot of those. But curious if you guys have done any scenario testing of how the business and/or in-ground portfolio would fare through some of the more aggressive plans that you have like tariffs and/or mass deportations where the outcome is a little bit muddier for us.
Tariffs, obviously, as a firm, we've worked through tariffs before in the firm's history. And so you can be assured at the portfolio company level and at -- in the C-suite, we risk-manage around any number of scenarios, not just around things like that. But this is going to have to be a wait-and-see in terms of how policy gets implemented.
Where we benefit from is the diversity of the franchise, both across industry groups and also, obviously, geographically. But obviously, this is something that all industries will focus on as we move forward. But there are no unique issues for Carlyle.
Our next question comes from the line of Brian McKenna from Citizens JMP.
So it's great to see the significant step-up in net accrued performance fees in the quarter, which clearly has positive implications on future earnings over time. But with the vast majority of this ultimately moving to cash on the balance sheet once realized, how should we think about deploying this excess capital over time, specifically as it relates to organic growth, strategic M&A, as well as buybacks?
Yes, Brian, it's John. Thanks for the question. I mean, look, we think of capital allocation just more broadly of where we can get the best return. And there are a couple of levers, I think, we have as a firm. One of them is a share buyback, which we've been very active on that front. The other one is investing in the businesses for organic growth.
We're very focused on organic growth. That is our first priority. We talked about it all the time. And the other area is inorganic opportunities, is another area where we can allocate capital. I would just say we look at a lot of stuff. Obviously, we had shown everything.
Where we sit today, we think we can get the best returns for our shareholders investing into our business for organic growth and continuing to do a share buyback. That said, if something came along inorganically that strategically made sense, financially made sense, we would be open to -- we wouldn't hesitate.
But where we sit today, nothing is imminent. We're very focused on organic growth and continuing to buy back shares. Remember, we've done nearly $500 million year-to-date, we have $900 million remaining on the share buyback authorization. And we're just really balancing our objectives of returning capital to shareholder and focusing on organic growth.
And our next question comes from the line of Glenn Schorr from Evercore ISI.
I think we'd all love to see the pickup in M&A and IPOs and better capital markets activity. And there's only -- the short-term downside maybe is less or no net asset growth if outflows are bigger than fundraising like you saw a little bit this quarter. So when I look at the 2% growth in management fees year-on-year, I don't feel like it reflects what the real underlying growth is in what's going on in the momentum that you've highlighted.
So curious how we should think about is there a path to double-digit management fee growth as you start to deploy all that dry powder that you have.
It's John. Look, we had fee revenue growth of 7% in the quarter. A lot of this was driven by our capital markets capabilities. Look, this has been a focus area for the management team, and we're very pleased with the progress we've made in terms of capital markets.
And I think you need to take a step back and look at our capital markets in the sense it's a balance sheet light business. We really aren't taking balance sheet risk. And again, we're only focused on Carlyle-related capital markets activity. So I think it's a little different than others in the industry.
This business has grown 80% this year, will generate a record result this year. So we feel very good about our capital markets effort. And again, this has been a very deliberate focus area for the firm.
In terms of management fees, we're seeing really strong management fee growth in solutions. It's up nearly 45%. We're seeing good management fee growth in credit. That grew nearly 11%. And look, as expected, we're still seeing some headwinds in our private equity business in terms of management fee growth, more on the corporate private equity side. We're in the market raising a real estate fund, and we're very optimistic on that outcome. And we've said in the past that fund will be larger than the previous fund.
But in terms of corporate private equity, we've been very focused on the performance in this business. We really like the trajectory of this business. And we're confident that we can grow this business over time.
I would just say, Glenn, I agree with your first statement. Sitting here, being in the seat now for a bit over 1.5 years, the momentum in the franchise is really just starting to translate into the top line, whether it's in wealth, credit, asset-based finance, the insurance strategy, credit solutions, and in private equity. So the momentum feels quite good.
Our next question comes from the line of Mike Brown from Wells Fargo Securities.
So it seems like at this point, Harvey, 1.5 years plus into the job, the foundation is kind of in place and established at Carlyle. As you think about the next few years, what is the right way to think about the annual fundraising potential? Is this kind of $40 billion level what Carlyle can kind of deliver on an annual basis?
And then also the FRE growth potential from here. I guess if you think about that kind of multiyear horizon, can Carlyle get to a point of delivering low double-digit FRE growth annually?
Yes. So 1.5 years in, I would say, the first principles really was just making sure we had all the right people in the right seats with the right capital strategy, the right expense methodology and, of course, the right leadership and I made a number of appointments, as you know, over that time period.
Now in terms of the future strategy, when you think about FRE growth, you really have to look at these areas that are emerging quite powerfully. So capital markets, which John just said this, the quality of those revenues is exceptionally high because we're basically running a balance sheet light, riskless business. And we see runway there.
The wealth channel, the Carlyle brand resonating around the world, really hard to model that over the next several years. But we're at a point where we've really only launched our second solution, we'll launch our private equity solution last year -- I'm sorry, next year. But the momentum when I talk to advisers and you see it in the numbers this quarter, so there's momentum across the firm.
In terms of fundraising, we put out this target this year of $40 billion, that was really just to give you some comfort with me being new in the seat. We'll think about how we communicate that over time. I think one of the things we did was we unfortunately left you with the feeling that that's going to be like a lockstep mathematical divided by 4, $10 billion every quarter. But I can tell you that, again, it's early days still at 18 months, but the momentum feels pretty extraordinary.
And our next question comes from the line of Brian Bedell from Deutsche Bank.
Maybe just, Harvey, if I can go back to the tariffs topic, just from a global trade perspective and deployment outside the U.S. How are you viewing that potential landscape? Do you see any frictions in deployment regionally? And are you thinking -- I guess, how are you thinking about deployment firm-wide between Europe and Japan? And any impact from the tariffs there?
So again, on the tariffs, I think it's very difficult for any firm, any business, global or local, to try and anticipate government policy. And I actually think it would be, in my opinion, an advice mistake to be changing strategy. Now you could prepare for any number of scenarios. And world-class management teams do that.
In terms of our franchise, remember, we are global, but in many cases, very local. So if you look at our Asia business, we're one of the few that have a leading Japan franchise. Our Asia business spans Southeast Asia, India, China. And so we have these -- the benefit of being global with a very regional capability. I think that's an advantage. Now I think that's an advantage in any environment.
But again, I think you can have -- you can game-theory out various things, so you're more prepared. But I think expectations around tariffs, that's just something we're going to have to see.
I think that where we can feel much more confident is around regulatory touch tax policy and all the things that will be really powerful elixirs for the market and for exits and for investing opportunities. But there will always be these elements of uncertainty on the periphery, but we'll see how they resolve over time.
And our next question comes from the line of Brennan Hawken from UBS.
So interested to talk about the fundraising point. It's and I might be reading too much into this, but it seems like now you're talking about 40, and the pace is in sort of like upper mid-20s year-to-date, so a little behind the pace of 40. Was the about 40 meant to -- meant as a softener around that number? And how should we be thinking about the fourth quarter? What are the drivers that will come through? And also just to confirm, did you close the Real Estate X Fund in the third quarter?
Brennan, it's John. I'll start with that, and Harvey, feel free to add. Look, I'll echo a little bit what Harvey said on fundraising. We feel very good about the momentum we have in fundraising across the franchise. You alluded to it, the number, we're $26 billion year-to-date. That's the second-best year-to-date period we've ever had in our history. So I think we have a lot of momentum.
We have pretty good visibility into the fourth quarter. The fourth quarter looks strong. So we'll get in and around 40. It's really hard to manage the business from a fundraising perspective to a specific number stuff. Stuff moves forward, stuff moves back. And I focus much more on it over a longer period of time. I think we'll get close to the 40, maybe we exceed it slightly, maybe we underachieve it slightly.
But in terms of how we think about managing the business, it doesn't really matter because we look at it over a multi-quarter period. And quite frankly, we focus a little bit more on just the momentum we have across the franchise, whether that's in our asset-backed business. whether it's in solutions, whether it's in real estate, and Harvey touched on this, we're seeing great momentum in the wealth channel. And we continue to think that will be a big component of fundraising going forward.
So I guess I'd answer it more in terms of we feel very good about the momentum we have going into the fourth quarter and next year.
Yes. I guess we really weren't trying to signal anything with the about. I think that there's things we have 100% control over or more control over, like how we're driving FRE into the end of the year, where we can give you more certainty.
If we have a handful of important clients who say, "Hey, we wanted to delay some decision-making for the election" or whatever reason, "we'd like you to extend some things," we -- look, we'll work with our clients. And so we don't manage fundraising for the purposes of hitting a number. We manage fundraising for the purpose of deployment running the business and really for our clients' needs. That's why you hear that.
But if I gave you the impression at the beginning of the year that 40 was a hard number, but maybe I should have said either side of 40. So anyway -- but no, there's no big signaling here, other than the momentum feels great.
And our next question comes from the line of Steven Chubak from Wolfe Research.
So I was hoping you could help frame the revenue opportunity in capital markets. With deal activity poised to accelerate, you noted you're seeing momentum across the franchise. Just trying to gauge how you think about an achievable run rate for this business and whether you're adequately resourced at least in relation to the opportunity that you envisage?
So in terms of resourcing, yes, we feel completely well resourced. The changes we made last year, [ I forgot here ], were very specific around prioritization, focus, alignment incentives and that's why you're seeing the results you're seeing. Again, with Q4 activity, it's already a record for the firm, and this is really against a, I think, a pretty quiet environment given what we may see.
I think the strategic tipping point is at what point does this -- if it becomes more of a balance sheet intensive business for us? But we have a lot of runway before we get there. And so I think we have a lot of capacity. And deal activity will drive more activity.
Giving you a runway is a little difficult because it's like saying, hey, can you forecast economic activity next year? But I can tell you all the pieces of the engine are in the proper place now.
Yes, Steve, I would just echo what Harvey said. We're going to have a record year across the platform in terms of capital markets revenue. And I would just repeat, this was in a relatively quiet market. And as markets continue to improve, we are very comfortable that we think that number should continue to accelerate.
And our next question comes from the line of Bill Katz from TD Cowen. .
Just maybe a slightly different tack on FRE. You've done a very good job of enhancing the FRE margin, as you mentioned, year-on-year, and if you look at the different segments, it's up very strongly. What's the algorithm for next year as we look ahead? How much more incremental margin can you shoot for?
And then just to have a secondary question. Just given the interplay between where you're growing assets, where you're realizing assets, how do we think about the interplay between fee paying AUM growth versus the base management fee rate?
Well, before -- I'm going to have John come into some of those details. But before we do that, I want to just I want to take a victory lap for John and the whole management team, because in a period of several months last year, they completely structured the compensation methodology, introduced it, introduced expense-saving initiatives. And I think they've accomplished an incredible amount in a very short period of time, and really set the foundation for how to run the firm.
Personally, I think there's more upside. But on some of the details, I'll turn it over to John. But he won't pat himself on the back, so -- or his team up, but I'll do that for him. John?
Yes, Bill, look, we feel very good about FRE. We had a record year. As I said in my remarks, we're clearly on path to hit $1.1 billion for the year. We have good visibility on the fourth quarter.
We're very pleased with where the margin is. It's at 47%. Again, let's put this in perspective. This is 1,000 basis points higher than it was last year, probably 2,000 basis points higher than it was 5 years ago. So we've made tremendous progress.
But look, the way the management team thinks about this business is we are much more focused on growth. And I would like to see the FRE margin grow via organic growth versus more efficiencies. I think there's -- we'll get a little bit from running the business efficiently, and we'll continue to run the business efficiently. But I think you could expect to see that margin improve as we grow over time.
And our next question comes from the line of Michael Cypress from Morgan Stanley.
Just wanted to ask about asset-based finance, a meaningful growth opportunity for Carlyle. So hoping you could just update us on where that stands today just in terms of AUM, how that part of the business has been growing. And maybe talk about some of the steps you might take into '25 to accelerate growth of that platform. And to what extent might you look to expand platform capabilities here to best capture the opportunity set? .
Yes, it's John. Look, I think it's an enormous opportunity for the industry and for Carlyle. And I do think it will be a large driver of credit growth for us going forward. But I'd say, look, it's very early days in the ABS space. Again, I think this market is enormous. It's multiples of direct lending.
We obviously announced the Discover transaction a couple of months ago. It was a very high-profile transaction for us. That transaction is largely closed post the third quarter. So we're very pleased with that.
Look, this is a business we started from scratch organically a couple of years ago. We already have roughly $7 billion of AUM. The pipeline continues to be one of the stronger pipelines we see across the platform. And look, it's a mix of one-off portfolio purchases and flow arrangements. We have in place a handful of flow arrangements. I would expect that to continue to increase over time. But I think it will be a mix of kind of portfolio purchases and flow arrangements.
A couple of the flow arrangements that we have that you've probably heard us talk about in the past are Monogram, Triad, Unison, covering multiple different assets, and we have others. And you should expect us going forward to have more flow arrangements or more flow partnerships as the business continues to evolve. But we really like this business. We're really pleased with where the business is, and we think this business has a lot of potential.
And our next question comes from the line Craig Siegenthaler from Bank of America.
Stock-based comp is now run-rating between 120 and 130 after the grants earlier this year. And I believe you commented on prior calls that there should be a step-down next year in 2025. However, I also believe the mechanics of the issuance is related to the price of the stock, which is higher today. So I just wanted your perspective on how we should be forecasting stock-based comp next year relative to where it came in this past quarter.
Craig, it's John. Good to hear from you. And I've said this on previous calls, a little bit of this is around the specific accounting treatment for the performance stock units. As you recall, from an accounting perspective, we are expensing them heavily upfront versus when they actually vest. And you've seen our stock-based comp at elevated levels the last few quarters. It's elevated today in the third quarter. It will continue to be at the third quarter level in the fourth quarter. But in 2025, we do expect to see that stock-based comp number trend down to more normalized levels.
Again, this is the accounting phenomenon of the grants that we gave. One of the things that we strategically did obviously is announcing the share buyback in advance of those awards, which are much higher stock levels. We already bought back a significant portion of anything associated with that dilution. So that's why you're seeing these dilution numbers look so attractive, certainly relative to the all the years prior to John and I doing this. This is the first 2 years dilution hasn't been a negative.
Yes. I mean, Craig, the last 2 years, the share count is actually down. It's down 1% this year. And look, we're very focused on repurchasing shares.
Thank you. And this does conclude the question-and-answer session of today's program. I'd like to hand the program back to Daniel Harris for any further remarks.
Thank you all very much for your time and attention today. Should you have any follow-up questions, feel free to reach out to Investor Relations after the call. We look forward to talking with you again next quarter.
Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day.